---
$id: https://graph.org.ai/products/commodity/51263112
$type: Product
source: UNSPSC
code: "51263112"
title: "Bucindolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bucindolol

**UNSPSC Code**: 51263112
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C22H25N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E9UO06K7CE, chemically known as 2-(2-hydroxy-3-((2-(1h-indol-3-yl)-1,1-dimethylethyl)amino)propoxy)benzonitrile but generally known as bucindolol, which bears US NIH Compound Identifier 51045. Bucindolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bucindolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05945MIG. The term BUCINDOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). BUCINDOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bucindolol under HS 29339990 and SITC 51577. As of Q4 2014, BUCINDOLOL remains the US FDA Preferred Term for this commodity. Bucindolol bears US NLM identifiers UMLS ID C0054196 and NCI Concept Code C79557. SMILES: OC(CNC(CC1C2C([NH]C1)CCCC2)(C)C)COC1C(CCCC1)C#N.

